Bristol Myers Squibb · 1 day ago
Associate Director, Oncology Clinical Biomarker Asset Lead, Translational Development
Boston, MA
Full-time
Onsite
Lead/Staff, Director/Executive
$214K/yr - $259K/yr
5+ years expBristol Myers Squibb is a leader in immuno-oncology therapies and is committed to advancing drug development for cancer treatment. The Clinical Biomarker Asset Lead will be responsible for developing and executing translational strategies in solid tumor oncology, leading biomarker strategies for clinical programs and collaborating with cross-functional teams.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Integrate translational research and clinical development, developing biomarker strategies in alignment with clinical development objectives, leading efforts for data generation and interpretation and for communication to the development teams
Responsible for understanding external research environment, partnering with other functions both internally and externally to coordinate the execution of Translational development deliverables
Engages functional groups to develop, champion, implement and align biomarker strategies for development projects in support of the overall R&D portfolio goals
Effectively engages with teams and matrix leadership to define, revise and progress translational biomarker plans
Continually analyzes progress, engages in critical thinking, and asserts strong problem-solving towards delivering key data and interpretations essential for decision making
Delivers high quality biomarker strategies for understanding mechanism of action/resistance, target engagement, pharmacodynamics endpoints and patient selection
Ensures the output of the biomarker plans meets established project standards
Engages team members to ensure alignment of biomarker strategies with clinical operational plans and with functional area capabilities to execute and deliver on robust translational biomarker data package to support trial and program
Builds productive relationships with team members that interact with the translational clinical biomarker group
Effectively interfaces with functional areas to ensure strategic alignment and to identify resources needed to deliver on biomarker goals
Productively engages with external collaborators and scientific KOLs to support translational goals
Communicates key biomarker program information, risks, and milestones, and manages information flow across team members
Qualification
Required
Ph.D. in Oncology/immunology or related field
5-8+ years of industry experience
3-5 years in oncology/biomarkers/translational or correlative research
Previous experience as Biomarker Lead for late-stage clinical trials; Experience in phases II/III required
Requires comprehensive knowledge of principles, concepts and / or methodologies within drug discovery or clinical development
Has significant understanding of the role of translational research/medicine and clinical biomarkers in drug development
Demonstrated knowledge of oncology and/or tumor-immunology disease biology
Regulatory submissions drug approvals in solid tumor space also highly desirable
In-depth understanding of solid tumor oncology with knowledge of current and evolving clinical landscape and competitive scenarios
Strong scientific background with understanding of clinical, translational, and mechanistic data with proven track record of publications
Understanding of early or late-stage drug and translational development process; including experience with implementing a biomarker strategy
Clinical protocol authoring and review of regulatory documents
Working knowledge of technological platforms covering biomarker measures including but not limited to genomics, gene expression, immune profiling, and flow cytometry
Excellent data analysis and problem-solving skills
Exceptional verbal and written communication skills with experience in developing written documents such as primary manuscripts/publications/reviews, scientific presentations and regulatory submissions (INDs/NDAs) with ability to synthesize complex scientific concepts into simple communication points
Proven scientific/project leadership expertise and experience working in global teams and managing people/projects
Benefits
Health Coverage: Medical, pharmacy, dental, and vision care.
Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off
US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Up to 2 paid volunteer days per year
An annual Global Shutdown between Christmas and New Years Day.
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
10001+ employees
H1B Sponsorship
Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)
Funding
Current Stage
Public CompanyTotal Funding
$29.32BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Charles Bancroft
CFO
Cristian Massacesi
Executive Vice President, Chief Medical Officer and Head of Development
Recent News
2026-01-09
2026-01-08
2026-01-07
Company data provided by crunchbase